about
Drug screen targeted at Plasmodium liver stages identifies a potent multistage antimalarial drugVisualisation and quantitative analysis of the rodent malaria liver stage by real time imagingTransition of Plasmodium sporozoites into liver stage-like forms is regulated by the RNA binding protein PumilioA novel type of catalytic copper cluster in nitrous oxide reductaseBiochemical and crystallographic studies of the Met144Ala, Asp92Asn and His254Phe mutants of the nitrite reductase from Alcaligenes xylosoxidans provide insight into the enzyme mechanismGenistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategyA caged lanthanide complex as a paramagnetic shift agent for protein NMR.Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection.A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity.Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events.Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activitiesBioluminescence Method for In Vitro Screening of Plasmodium Transmission-Blocking Compounds.Uptake and metabolism of arginine impact Plasmodium development in the liverHost-cell sensors for Plasmodium activate innate immunity against liver-stage infectionLoss-of-function analyses defines vital and redundant functions of the Plasmodium rhomboid protease family.Use of a selective inhibitor to define the chemotherapeutic potential of the plasmodial hexose transporter in different stages of the parasite's life cycleInnate immunity induced by Plasmodium liver infection inhibits malaria reinfections.Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy.Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.Marilones A-C, phthalides from the sponge-derived fungus Stachylidium spNovel potent metallocenes against liver stage malaria.Transient complexes of redox proteins: structural and dynamic details from NMR studies.Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites.Antimalarial drugs - host targets (re)visited.The silent path to thousands of merozoites: the Plasmodium liver stage.The relevance of host genes in malaria.To migrate or to invade: those are the options.Torins are potent antimalarials that block replenishment of Plasmodium liver stage parasitophorous vacuole membrane proteins.Interactions of the malaria parasite and its mammalian host.Plasmodium berghei-infection induces volume-regulated anion channel-like activity in human hepatoma cellsImidazoquines as antimalarial and antipneumocystis agents.Illuminating the host - how RNAi screens shed light on host-pathogen interactions.GLUT1-mediated glucose uptake plays a crucial role during Plasmodium hepatic infection.A toolbox to study liver stage malaria.Targeting the liver stage of malaria parasites: a yet unmet goal.Targeting host factors to circumvent anti-malarial drug resistance.Inhibition of Plasmodium Hepatic Infection by Antiretroviral Compounds.Enantiopure Indolizinoindolones with in vitro Activity against Blood- and Liver-Stage Malaria Parasites.Dual-stage triterpenoids from an African medicinal plant targeting the malaria parasite.
P50
Q24613311-537C4DC6-91D6-4A76-B0EC-F086A13A6E67Q27335248-FBC46511-9831-4CD2-8765-0B142589ED8CQ27349937-B42192DF-042D-41F5-917E-3AA9468DDE74Q27621620-54A6641E-558F-421A-BC28-0470B0D1A0A9Q27637651-84B69435-4595-4483-80F7-0DDA7AAF13CFQ28473154-F76937E7-7F32-4ADD-87CC-DEC7026A0888Q30342068-E4F6EC21-A8ED-4C96-AFDD-C96F2142EEB9Q33383241-6CAEEC8F-4B15-474E-A772-20FBEB2906FCQ33425212-DE9FD2BF-7011-46DF-9F15-D4D7A73C75D6Q33469999-6D6CE350-0295-48E9-AFD2-D5ABE8A210C7Q33636502-3E1A7D83-35C9-4193-9AA1-987F8D1EC128Q33726679-E9F19725-4B37-4D66-A15B-CB595260ECE9Q33826192-D929633A-5385-43FD-9B18-2C7187B54E96Q33896690-12D58C72-21B8-47B6-A69D-C24A08D2CB5EQ34332951-B1291FE8-6FFD-436A-8789-D3FAC350E82AQ35005159-7A11E30A-EDB4-421A-8640-234B2E142F2FQ35098216-4294566B-3422-4D70-BC50-D25F123FEEA4Q35270733-137A7C8F-8086-43A9-B473-008EBB2AF8A8Q35580148-B74FD9DF-C8F3-46DB-BAEF-EF0542B11A89Q35657445-B3E34634-4E52-4C0A-9990-69A25F836A9DQ35806217-B1E9512A-BB51-414B-858B-069D73AE061CQ35896267-3579925A-72B2-4033-AAB0-A9F489E607D1Q36001246-00DAF234-6690-433D-A7D9-1BA302B5A3F9Q36107459-525F79C9-5053-4A0B-A183-6F02470DADA5Q36560632-F72FFF56-1BD8-4AB6-B412-FF43D58D01EEQ36623691-78CC08BB-F56A-44F1-8937-39132A401C75Q36869042-AE6EFB03-2624-4C6B-8835-4B0DEBCE82EBQ37001773-F5266CC7-AC52-4FE3-AF7C-0D4E4A6692D5Q37049536-DF21E43F-C688-41EA-BC9B-4DFCB162ED55Q37222834-694040E3-051D-4FD2-8B10-93346C74A5DCQ37414552-874D6DF4-867E-4781-9DB4-07DEBCE1AAD0Q37459170-FD78F033-71B1-42FC-9107-92AEBE12D95AQ37511946-F08BB981-662E-4779-B413-6DD9FAAF5DEAQ37631769-BC6655AA-D76B-4E29-A1C7-C4725997AABFQ37947849-B3B394E2-C708-4DA3-BF98-6278BDE8BEADQ37961954-5FF9FBE0-45BC-48AD-B630-3D9EE159B095Q38042983-0C6D5ABB-105B-4D2C-8791-D5D7D426E660Q38695833-367FC76C-AE4E-4AB1-8520-29A5396A3AB3Q38822865-E0701E7D-DE6B-419C-8F9C-71EDC6410A1DQ38977340-43FF4692-57AF-4B1D-AE87-C965587963B0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Miguel Prudêncio
@ast
Miguel Prudêncio
@en
Miguel Prudêncio
@es
Miguel Prudêncio
@nl
Miguel Prudêncio
@sl
type
label
Miguel Prudêncio
@ast
Miguel Prudêncio
@en
Miguel Prudêncio
@es
Miguel Prudêncio
@nl
Miguel Prudêncio
@sl
prefLabel
Miguel Prudêncio
@ast
Miguel Prudêncio
@en
Miguel Prudêncio
@es
Miguel Prudêncio
@nl
Miguel Prudêncio
@sl
P1053
D-2032-2012
P106
P1153
6603561872
P21
P2798
P31
P3829
P4012
P496
0000-0003-1746-6029